Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group

  1. Martin, M.
  2. Villar, A.
  3. Sole-Calvo, A.
  4. Gonzalez, R.
  5. Massuti, B.
  6. Lizon, J.
  7. Camps, C.
  8. Carrato, A.
  9. Casado, A.
  10. Candel, M.T.
  11. Albanell, J.
  12. Aranda, J.
  13. Munarriz, B.
  14. Campbell, J.
  15. Diaz-Rubio, E.
Revista:
Annals of Oncology

ISSN: 0923-7534

Any de publicació: 2003

Volum: 14

Número: 6

Pàgines: 833-842

Tipus: Article

DOI: 10.1093/ANNONC/MDG260 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus